Predict your next investment

HEALTHCARE | Drug Delivery
pulsetherapeutics.com

See what CB Insights has to offer

Total Raised

$15.78M

Investors Count

9

Deal Terms

2

Pulse Therapeutics Funding, Pulse Therapeutics Valuation & Pulse Therapeutics Revenue

7 Fundings

Pulse Therapeutics's latest funding round was a Merger for on January 8, 2019.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/8/2019

Merger

$0.00B

((9.99x))

FY 1234

1

1/27/2016

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

2/6/2014

Series A - III

$99M

$0.00B

((9.99x))

FY 1234

10

1/13/2012

Series A - II

$99M

$0.00B

((9.99x))

FY 1234

10

4/21/2011

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

1/8/2019

1/27/2016

2/6/2014

1/13/2012

4/21/2011

Round

Merger

Series B

Series A - III

Series A - II

Series A

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Pulse Therapeutics Deal Terms

2 Deal Terms

Pulse Therapeutics's deal structure is available for 2 funding rounds, including their Series A - III from February 06, 2014.

Round

Series A - III

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A - III

$99M

$99M

$99M

$99M

Series A

Pulse Therapeutics Investors

9 Investors

Pulse Therapeutics has 9 investors. FTL Capital invested in Pulse Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/21/2011

1/27/2016

4
Series A, Series A - II (2012), Series A - III (2014), Series B (2016)

Thomas Hillman

Private Equity

Missouri

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Cayman Islands

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Missouri

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Non-Profit Foundation

Missouri

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Academic/University

Missouri

First funding

4/21/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/27/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

4
Series A, Series A - II (2012), Series A - III (2014), Series B (2016)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Thomas Hillman

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Private Equity

Venture Capital

Venture Capital

Non-Profit Foundation

Academic/University

Location

Missouri

Cayman Islands

Missouri

Missouri

Missouri

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.